Michael Innocenzo - Feb 3, 2025 Form 4 Insider Report for EXELON CORP (EXC)

Role
EVP & Chief Operating Officer
Signature
David T Skinner, attorney-in-fact for Michael Innocenzo
Stock symbol
EXC
Transactions as of
Feb 3, 2025
Transactions value $
-$423,470
Form type
4
Date filed
2/4/2025, 05:12 PM
Previous filing
Apr 2, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock Options Exercise +2.35K +3.58% 67.9K Feb 3, 2025 Direct F1
transaction EXC Common Stock Options Exercise +2.34K +3.45% 70.2K Feb 3, 2025 Direct F1
transaction EXC Common Stock Options Exercise +5.54K +7.89% 75.8K Feb 3, 2025 Direct F1
transaction EXC Common Stock Options Exercise +10.8K +14.19% 86.5K Feb 3, 2025 Direct F2
transaction EXC Common Stock Tax liability -$274K -6.75K -7.8% $40.57 79.8K Feb 3, 2025 Direct
transaction EXC Common Stock Disposed to Issuer -$150K -3.69K -4.63% $40.57 76.1K Feb 3, 2025 Direct
holding EXC Common Stock ESPP 2.64K Feb 3, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC 2022 Restricted Stock Units Options Exercise -2.35K -100% 0 Feb 3, 2025 Common Stock 2.35K Direct F1, F3
transaction EXC 2023 Restricted Stock Units Options Exercise -2.34K -49.99% 2.35K Feb 3, 2025 Common Stock 2.34K Direct F1, F4
transaction EXC 2024 Restricted Stock Units Options Exercise -5.54K -33.34% 11.1K Feb 3, 2025 Common Stock 5.54K Direct F1, F5
transaction EXC 2025 Restricted Stock Units Award $0 +22.4K $0.00 22.4K Feb 3, 2025 Common Stock 22.4K Direct F1
transaction EXC 2022-2024 Performance Shares Award $0 +10.8K $0.00 10.8K Feb 3, 2025 Common Stock 10.8K Direct F2
transaction EXC 2022-2024 Performance Shares Options Exercise -10.8K -100% 0 Feb 3, 2025 Common Stock 10.8K Direct F2
holding EXC Deferred phantom share equivalents 2.2K Feb 3, 2025 Common Stock 2.2K Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit (RSU) award granted under the Exelon Long-Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Talent Management and Compensation Committee (TMCC) with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues additional RSUs each quarter through automatic dividend reinvestment, and the additional RSUs vest on the same schedule as the underlying award.
F2 Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the TMCC's determination of performance achieved for the period. Each performance share represents the right to receive one share or the cash equivalent of one share pursuant to the LTIP's terms with respect to individual stock ownership levels. Performance share awards vest immediately on their grant date.
F3 Balance at the time of this vesting includes 93 additional shares acquired through automatic dividend reinvestment during 2024.
F4 Balance at the time of this vesting includes 187 additional shares acquired through automatic dividend reinvestment during 2024.
F5 Balance at the time of this vesting includes 576 additional shares acquired through automatic dividend reinvestment during 2024.
F6 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. The stock fund is a unitized fund that consists of both Exelon common stock and short-term liquid investments. Units of the fund are acquired through quarter-end contributions and dividend reinvestment and will be settled for cash upon the termination of the reporting person. The balance of phantom share equivalents may fluctuate due to changes in the value of the fund units.
F7 Balance as of January 31, 2025. Balance includes 82 additional phantom share equivalents acquired during 2024 through automatic dividend reinvestment.